Page last updated: 2024-12-06

1-phenyl-3,3-dimethyltriazene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-phenyl-3,3-dimethyltriazene (PDT) is an organic compound with the chemical formula C9H13N3. It's a colorless liquid that is often used in chemical research for a variety of reasons:

**Properties and Applications:**

* **Diazo Coupling Reagent:** PDT is a key component in diazo coupling reactions. These reactions are used to synthesize a wide range of azo dyes, which are important pigments and colorants in various industries.
* **Nitrosating Agent:** PDT can also act as a nitrosating agent. This property is utilized in organic synthesis to introduce nitro groups onto organic molecules.
* **Photochemistry:** PDT is a photolabile compound, meaning it decomposes upon exposure to light. This property makes it a valuable tool in photochemistry for the study of photochemical reactions and the development of photosensitive materials.

**Why it's important for research:**

* **Synthesis of New Compounds:** PDT plays a vital role in the synthesis of various new compounds, particularly azo dyes and nitro-containing molecules. These compounds have diverse applications in industries like pharmaceuticals, textiles, and pigments.
* **Mechanistic Studies:** Its photolabile nature allows researchers to study photochemical reactions and explore the mechanism of light-induced decomposition.
* **Development of New Materials:** PDT's photochemical properties are being investigated for potential applications in the development of new photosensitive materials like photoresists and photochromic compounds.
* **Drug Discovery:** PDT has also been explored as a potential drug candidate due to its reactivity and potential for selective targeting.

**Safety Considerations:**

It's important to note that PDT is a reactive compound that should be handled with care in a well-ventilated laboratory environment. Proper safety precautions, including wearing protective gear and working under a fume hood, are essential when handling this substance.

In summary, 1-phenyl-3,3-dimethyltriazene (PDT) is an important research chemical with diverse applications in synthesis, photochemistry, and material science. Its unique properties make it a valuable tool for developing new compounds, studying chemical reactions, and exploring potential applications in various fields.

Cross-References

ID SourceID
PubMed CID23654
CHEMBL ID1981220
CHEMBL ID3188118
SCHEMBL ID187587
SCHEMBL ID2109239
MeSH IDM0053059

Synonyms (40)

Synonym
nsc3094
nsc-3094
3,3-dimethyl-1-phenyltriazene
1-phenyl-3,3-dimethyltriazene
1-triazene,3-dimethyl-1-phenyl-
7227-91-0
wln: 1n1&nunr
pdmt
triazene,3-dimethyl-1-phenyl-
x 119
1-triazene, 3,3-dimethyl-1-phenyl-
triazene, 3,3-dimethyl-1-phenyl-
NCI60_002653
(1e)-3,3-dimethyl-1-phenyltriaz-1-ene
ccris 507
3,3-dimethyl-1-phenyl-1-triazene
ai3-22123
brn 0907506
nsc 3094
einecs 230-627-7
1-fenyl-3,3-dimethyltriazin
n-methyl-n-phenyldiazenylmethanamine
AKOS006282831
cas-7227-91-0
dtxsid5021128 ,
NCGC00255139-01
dtxcid101128
tox21_301876
unii-79r3zf226y
79r3zf226y ,
4-16-00-00903 (beilstein handbook reference)
SCHEMBL187587
SCHEMBL2109239
LLROQAGEAVDYFP-MDZDMXLPSA-N
3,3-dimethyl-1-phenyl-1-triazene #
CHEMBL1981220
dimethyl-1-phenyltriazene, 3,3-
CHEMBL3188118
3,3-dimethyl-1-phenyltriazen
Q27266771

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The close correspondence of the two QSAR leaves essentially no means for the synthesis of more potent, less toxic triazenes."( Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
Greenberg, N; Hansch, C; Hatheway, GJ; Quinn, FR, 1978
)
0.26
" Thus, to develop the molecular PSs for the improved and safe PDT in clinic, a novel and versatile PS (Mal-Pc) has been designed by di-substituting maleimides to the axial positions of silicon (Ⅳ) phthalocyanine."( Novel molecular photosensitizer with simultaneously GSH depletion, aggregation inhibition and accelerated elimination for improved and safe photodynamic therapy.
Chen, J; Huang, K; Xue, J; Yan, M, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" Exposure to single intraperitoneal doses of DMPT on gestation day 20 did not produce a classic dose-response pattern: Minimal effects were observed with 10 mg DMPT/kg (occasional renal mesenchymal tumors and brain neoplasms), marked effects were observed with 30 mg DMPT/kg (lower incidence rate of most of the alterations observed with 1 mg/kg on gestation days 16, 18, and 20), and no effects were observed with 60 mg DMPT/kg."( Renal transplacental carcinogenicity of 3,3-dimethyl-1-phenyltriazene in rats: relationship of renal mesenchymal tumor to congenital mesoblastic nephroma and intralobar nephrogenic rests.
Beckwith, JB; Carlton, WW; Frank, AA; Heidel, JR; Thompson, DJ, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency70.62170.006038.004119,952.5996AID1159521; AID1159523
aryl hydrocarbon receptorHomo sapiens (human)Potency76.95880.000723.06741,258.9301AID743085
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1148441Toxicity in rat assessed as concentration required for producing T/C of 1401978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
AID1132827Aqueous phase distribution coefficient, log P of the compound in phosphate buffer at pH 7.41978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
AID1148443Toxicity in CDF1 mouse assessed as concentration required for producing T/C of 1401978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
AID1132823Distribution coefficient, log P of the compound1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
AID1132822Antitumor activity against mouse L1210 cells allografted in mouse assessed as increase of host lifespan1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
AID1123539Mutagenicity in Salmonella typhimurium strain TA92 assessed as number of bacterial revertants after 2 days by Ames test in presence of rat liver S9 fraction1979Journal of medicinal chemistry, May, Volume: 22, Issue:5
Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study.
AID1148444Lipophilicity, log P of the compound1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (29.17)18.7374
1990's7 (14.58)18.2507
2000's7 (14.58)29.6817
2010's3 (6.25)24.3611
2020's17 (35.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.05 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.08%)6.00%
Case Studies1 (2.08%)4.05%
Observational0 (0.00%)0.25%
Other46 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]